首页> 外文期刊>Cancer Management and Research >The Association Between Immune Characteristic and Clinical Pathology in Chinese Patients with Adenocarcinoma of Esophagogastric Junction
【24h】

The Association Between Immune Characteristic and Clinical Pathology in Chinese Patients with Adenocarcinoma of Esophagogastric Junction

机译:食管胃癌腺癌腺癌患者免疫特性与临床病理学的关联

获取原文
           

摘要

Purpose: Adenocarcinoma of the esophagogastric junction (AEG) patient immune characteristics were analyzed in this study, and these features were compared with patient clinical pathology and prognosis. Patients and Methods: The clinicopathological data and prognostic information of 96 AEG patients who were admitted to Ren Ji Hospital between December 2008 and December 2015 were collected. PD-1/PD-L1, Tim-3/Gal-9, and CD3/CD8/Foxp3 expression in these patients, as well as the correlation of the expression of these molecules with clinicopathological data and survival time, were analyzed. Comparisons of count data were performed using the chi-square test or Fisher’s exact test. The survival rate and survival curves were calculated and drawn, respectively, with the Kaplan–Meier method, and the Log rank test was used for survival analysis. Results: The positive rate for PD-L1 and Gal-9 in these AEG patients was 30.21% and 31.25%, respectively. Tim-3 positivity had a close relationship with patient Siewert type. CD8+ T cell infiltration and patient TNM stage, as well as CD3+CD8+ T cell infiltration and patient Lauren type, had a close relationship based on analysis of the correlation between immune factor expression and clinicopathological data. The group with high CD8+ T cell infiltration had an improved survival rate, while the combined analysis of Tim-3 and Gal-9 expression showed that the double-positive group had a significantly poorer prognosis than groups with other Tim-3 and Gal-9 expression patterns. The PD-L1 expression level had a close relationship with T cell infiltration in AEG patients, especially CD3+ and CD8+ T cell infiltration. Conclusion: Tim-3 expression was higher in patients with Siewert type I tumors than in patients with tumors of other Siewert types. Patients with high CD8+ T cell infiltration had a better prognosis than patients with low CD8+ T cell infiltration, and CD8+ T cell infiltration was closely related to AEG patient TNM stage. The Tim-3 and Gal-9 double-positive group showed poor prognosis, and immune therapy could be recommended for these AEG patients.
机译:目的:在本研究中分析了食管胃癌(AEG)患者免疫特性的腺癌,与患者临床病理和预后进行了比较这些特征。患者及方法:收集了2008年12月至2015年12月在2015年12月期间录取任继医院的96名AEG患者的临床病理数据和预后信息。分析了PD-1 / PD-L1,TIM-3 / GAL-9和这些患者的CD3 / CD8 / FoxP3表达,以及这些分子表达与临床病理数据和生存时间的相关性的相关性。使用Chi-Square测试或Fisher的确切测试进行计数数据的比较。分别用Kaplan-Meier方法计算并绘制存活率和存活曲线,并将对数级试验用于存活分析。结果:这些AEG患者PD-L1和GAL-9的阳性率分别为30.21%和31.25%。 Tim-3积极性与患者Siewert类型密切相关。 CD8 + T细胞浸润和患者TNM阶段,以及CD3 + CD8 + T细胞浸润和患者劳伦型,基于分析免疫因子表达和临床病理数据之间的相关性分析。具有高CD8 + T细胞浸润的组具有改善的存活率,而TIM-3和GAL-9表达的组合分析表明,双阳性组的预后显着较差,而不是其他TIM-3和GAL-9的群体表达式模式。 PD-L1表达水平与AEG患者中的T细胞浸润性密切相关,尤其是CD3 +和CD8 + T细胞浸润。结论:Siewert I型肿瘤患者的TIM-3表达比其他Siewert类型的肿瘤患者更高。高CD8 + T细胞浸润的患者比低CD8 + T细胞浸润的患者具有更好的预后,CD8 + T细胞浸润与AEG患者TNM阶段密切相关。 TIM-3和GAL-9双阳性组显示出不良预后,可以推荐免疫治疗,用于这些AEG患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号